2-(AZOCAN-1-YL)-2-PHENYLACETIC ACID HCL, 95.0%, 1g

2-(4-Oxo-3-((5-(trifluoromethyl)benzo[d]thiazol-2-yl)methyl)-3,4-dihydrothieno[3,4-d]pyridazin-1-yl)acetic acid, 98.0%, 25mg

3-Thiomorpholinecarboxylic acid, 97.0%, 5g

1-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-1H-pyrazole, 98.0%, 5g

(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(3-bromophenyl)butanoic acid, 97%, 1g

(8-methylimidazo[1,2-a]pyridin-2-yl)methanol, 95.0%, 10g

(1R,4R)-tert-Butyl N-[4-(pyrimidin-4-ylamino)cyclohexyl]carbamate, 1g

Au en polvo 99,9+% 0,3-3 micrones 1 g

(1R,2S,5R)-6-(Benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxylic acid, 97%, 5g

1-(4-(HYDROXYIMINO)PIPERIDIN-1-YL)ETHANONE, 95.0%, 2g

N-Deshydroxyethyl Dasatinib, 98.02%, 100mg

2-Methylcyclohexanol (cis- and trans- mixture)>98.0%(GC)500mL

2-(4-Chloro-3,5-dimethylphenoxy)acetohydrazide, 95.0%, 1g